Invesco Ltd. Oramed Pharmaceuticals Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.51 - $3.55 $25,335 - $35,833	10,094 New	10,094 $26,000
Q1 2023 May 12, 2023	BUY	$1.93 - $13.1 $25,813 - $175,212	13,375 New	13,375 $29,000
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $53,456 - $129,330	-14,370 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $11,294 - $19,154	1,379 Added 10.62%	14,370 $124,000
Q4 2021 Feb 14, 2022	SELL	$12.98 - $29.75 $9.63 Million - $22.1 Million	-742,204 Reduced 98.28%	12,991 $186,000
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $9.02 Million - $17.7 Million	743,715 Added 6478.35%	755,195 $16.6 Million
Q2 2021 Aug 17, 2021	BUY	$8.34 - $14.59 $95,743 - $167,493	11,480 New	11,480 $154,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.